News
A DAILY weight loss pill, tipped to be cheaper than popular jabs, has helped patients shed nearly two stone in trials. People ...
A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.
With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...
(Reuters) -Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of ...
Experts fear that patients priced out of private Mounjaro treatment may now turn to the health service for support. Experts ...
Now, one Wegovy user who's been on the medication for only a week has shared an unexpected side effect of the drug - but they ...
France's medicine safety agency has decided to broaden access to Wegovy and Mounjaro, which are not reimbursed by the French ...
Experts fear that patients priced out of private Mounjaro treatment may now turn to the health service for support. Experts ...
In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.
Mounjaro price hikes have seen users across the UK scrambling to stock up before the price change, with a rise in fake weight loss jab pens for sale ...
Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...
8h
India Today on MSNEli Lilly's obesity pill clears final trial, paving way for global approval
Eli Lilly's Orforglipron helped patients with obesity and Type 2 diabetes lose over 10% body weight in phase 3 trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results